223 related articles for article (PubMed ID: 26982332)
1. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.
Shen M; Shi H
PLoS One; 2016; 11(3):e0151455. PubMed ID: 26982332
[TBL] [Abstract][Full Text] [Related]
2. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
3. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
[TBL] [Abstract][Full Text] [Related]
4. Effects of estradiol, estrogen receptor subtype-selective agonists and genistein on glucose metabolism in leptin resistant female Zucker diabetic fatty (ZDF) rats.
Weigt C; Hertrampf T; Flenker U; Hülsemann F; Kurnaz P; Fritzemeier KH; Diel P
J Steroid Biochem Mol Biol; 2015 Nov; 154():12-22. PubMed ID: 26134426
[TBL] [Abstract][Full Text] [Related]
5. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
6. GPER-independent effects of estrogen in rat aortic vascular endothelial cells.
Ding Q; Hussain Y; Chorazyczewski J; Gros R; Feldman RD
Mol Cell Endocrinol; 2015 Jan; 399():60-8. PubMed ID: 25150623
[TBL] [Abstract][Full Text] [Related]
7. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
8. Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing.
Shen M; Cao J; Shi H
Int J Endocrinol; 2018; 2018():5789127. PubMed ID: 30510575
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
Ren J; Chen GG; Liu Y; Su X; Hu B; Leung BC; Wang Y; Ho RL; Yang S; Lu G; Lee CG; Lai PB
PLoS One; 2016; 11(4):e0153863. PubMed ID: 27093553
[TBL] [Abstract][Full Text] [Related]
10. 17Beta-estradiol signaling and regulation of proliferation and apoptosis of rat Sertoli cells.
Royer C; Lucas TF; Lazari MF; Porto CS
Biol Reprod; 2012 Apr; 86(4):108. PubMed ID: 22219213
[TBL] [Abstract][Full Text] [Related]
11. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of the Effects of 17-Beta Estradiol on Proliferation, and Apoptosis in Hepatocellular Carcinoma Hep G2 and LCL-PI 11 Cell Lines.
Sanaei M; Kavoosi F; Dehghani F
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2637-2641. PubMed ID: 30256559
[TBL] [Abstract][Full Text] [Related]
13. High dose 17 beta-estradiol and the alpha-estrogen agonist PPT trigger apoptosis in human adrenal carcinoma cells but the beta-estrogen agonist DPN does not.
Prieto LM; Brown JW; Perez-Stable C; Fishman LM
Horm Metab Res; 2008 May; 40(5):311-4. PubMed ID: 18491249
[TBL] [Abstract][Full Text] [Related]
14. 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways.
Chen YH; Lee MJ; Chang HH; Hung PF; Kao YH
Endocrinology; 2006 Sep; 147(9):4496-504. PubMed ID: 16740979
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.
Zhao L; Brinton RD
Brain Res; 2007 Oct; 1172():48-59. PubMed ID: 17803971
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
17. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
18. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling.
Acconcia F; Totta P; Ogawa S; Cardillo I; Inoue S; Leone S; Trentalance A; Muramatsu M; Marino M
J Cell Physiol; 2005 Apr; 203(1):193-201. PubMed ID: 15389627
[TBL] [Abstract][Full Text] [Related]
19. Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities.
Cheng B; Song J; Zou Y; Wang Q; Lei Y; Zhu C; Hu C
Int J Cardiol; 2009 May; 134(3):356-65. PubMed ID: 18584900
[TBL] [Abstract][Full Text] [Related]
20. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.
Fang D; Yang H; Lin J; Teng Y; Jiang Y; Chen J; Li Y
Biochem Biophys Res Commun; 2015 Feb; 457(4):500-6. PubMed ID: 25592968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
